Trexquant Investment’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Trexquant Investment’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,445	Closed	-$485K	–	1924
2023 Q2	$485K	Sell	10,445 -11,364	-52%	-$393K	0.01%	1018
2023 Q1	$625K	Buy	21,809 +11,931	+121%	+$353K	0.02%	905
2022 Q4	$308K	Sell	9,878 -7,727	-44%	-$252K	0.01%	1095
2022 Q3	$357K	Sell	17,605 -4,892	-22%	-$89.1K	0.01%	951
2022 Q2	$349K	Buy	22,497 +6,413	+40%	+$110K	0.02%	1040
2022 Q1	$308K	Buy	+16,084	New	+$287K	0.01%	989

Trexquant Investment's DICE Position: Q3 2023 in Review

Trexquant Investment sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 10,445 shares — an estimated $485K sold.

Trexquant Investment first reported a position in DICE in Q1 2022 and held it in 6 quarters. The position peaked at $625K in Q1 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Trexquant Investment reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Trexquant Investment sold 10,445 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $485K.
Trexquant Investment first reported a position in DICE Therapeutics, Inc. Common Stock in Q1 2022 and held it in 6 quarters.
Trexquant Investment's DICE Therapeutics, Inc. Common Stock position peaked at $625K in Q1 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Trexquant Investment's 13F filing for Q3 2023, filed 13 Nov 2023.